Discovering a Common Goal,
Discovering a Cure

CONTACT  |  DONATE  |  E-NEWSLETTER  | 
  
DRUG NEWS

Research News
Drug News
Conference News
< Home



Crowdsourcing Project Predicts ALS Disease Progression
November 12, 2014
Although the majority of ALS patients survive only 2-5 years after diagnosis, the rate of disease progression varies significantly. This heterogeneity poses a major challenge for c...

Neuralstem Stem Cells Survive Long-Term Following Spinal Cord Transplantation in ALS Patients
November 12, 2014
Concurrent with the U.S.-based Phase II clinical trial of Neuralstem’s NSI-566 human spinal-cord derived neural stem cells (HSSC) as a treatment for ALS, the company has just pub...

Hypertension Drug May Reduce Risk of ALS
November 12, 2014
A new study suggests that angiotensin-converting enzyme inhibitors (ACEIs), widely prescribed medications for treating high blood pressure and coronary artery disease, may also dra...

AB Science Publishes Preclinical Data on Masitinib in Stroke
November 12, 2014
New data is emerging about the neuroprotective properties of masitinib, an inhibitor of the c-kit tyrosine kinase, which is currently in Phase III clinical trials for ALS. The drug...

Astrazeneca and University of Cambridge Partner on Neurodegenerative Disease Research
October 28, 2014
Astrazeneca, together with its biologics arm, Medimmune, has expanded its strategic alliance with University of Cambridge beyond oncology into research and development for neurodeg...





The ALS Forum was developed by Prize4Life, Inc.
 
© 2014 Prize4Life, Inc.
Identified content provided through
a partnership with the Alzforum